Every year 470,000 patients are placed on the ‘Urgent 2 week wait’ treatment pathway to find only 16,000 melanoma. Demand is growing while capacity is not.
Skin Analytics Service History
Skin Analytics have provided teledermatology services for over 5 years. In April 2020 we launched the first AI-supported Teledermatology service at University Hospitals Birmingham NHS Foundation Trust (see press release) using DERM. Our services help reduce the need for unnecessary secondary care referrals.
Derm takes seconds to assess skin lesions
Supports clinicians in the assessment of skin lesions
Class 1 CE Marked medical device
Skin Analytics platform is designed to help clinicians
- Safely reduce referrals and associated costs
- Improve health outcomes
- Better clinical governance
- Improve patient experience
- Ensure patient’s data is secure
Reducing costs and adding valuable benefits
DERM, our unique AI technology, supports clinicians in the assessment of skin lesions. These range from malignant and pre-malignant lesions that can be treated if assessed early enough, through to benign lesions where patients can be discharged or referred for further monitoring.
The Skin Analytics system also enables local dermatologists to review referred cases remotely, allowing them to direct patients to the best assessment or treatment option.
University Hospitals Birmingham NHS Foundation Trust’s skin cancer Community Clinic is using the Skin Analytics AI-supported Teledermatology Platform and service to help them safely reduce delays in skin cancer detection and treatment.